Survival analyses using the Kaplan-Meier plotter (Lanczky and Gyorffy 2021) showed that the level of ECM1 expression is not prognostic in the whole group of ER+ breast cancer patients (Figure 2(A)). This evidence concerns the gene ESR1 and breast cancer.